About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
All categories
All categories
News
Press releases
Press about us
Portfolio
Portfolio
Gemabank
Nextgen
Genetico
Biotechnology Developments
Betuvax
Histograft
Genotarget
Reprobank
Vitacel
14.08.2025
Press releases
Gemabank’s Board of Directors Recommends Dividends for 6 Months of 2025
13.08.2025
Press releases
RBT and the Almazov Center Will Develop New Medical Technologies and Products
07.08.2025
Press releases
Gemabank’s H1 2025 Results under Russian Accounting Standards
06.08.2025
Press releases
Genetico’s H1 2025 Results under Russian Accounting Standards
17.07.2025
Press releases
ACRA Affirms Credit Rating of IMCB, PJSC, at BBB-(RU), Outlook: Stable
16.07.2025
Press releases
Gene Therapy Drug Helped Patients with Arterial Injuries
14.07.2025
Press releases
ACRA Affirms Artgen Biotech’s Credit Rating at BBB–(RU)
1
2
3
4
…
22
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
